High Point, North Carolina
United States
67
2014-10-23
54
2014-12-09
These are the the leading inventors for applications assigned to HIGH POINT PHARMACEUTICALS, LLC:
HIGH POINT PHARMACEUTICALS, LLC based in High Point, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
N-adamantyl benzamides as inhibitors of 11-Ξ²-hydroxysteroid dehydrogenase
#2 | 2014-07-17 β Patent 10,030,011 granted on 2018-07-24Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
#3 | 2014-03-06 β Patent 8,946,259 granted on 2015-02-03Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors
#4 | 2014-01-23 β Patent 9,663,481 granted on 2017-05-30Phenoxy acetic acids and phenyl propionic acids as PPARΞ΄ agonists
#5 | 2013-09-26 β Patent 9,447,468 granted on 2016-09-20Compounds that modulate oxidative stress
#6 | 2013-09-05 β Patent 8,809,540 granted on 2014-08-19N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
#7 | 2013-04-25 β Patent 8,551,993 granted on 2013-10-08Phenoxy acetic acids as PPAR delta activators
#8 | 2013-03-28 β Patent 8,772,285 granted on 2014-07-08Benzothiazoles having histamine H3 receptor activity
#9 | 2012-09-13 β Patent 8,426,473 granted on 2013-04-23Phenoxy acetic acids as PPAR delta activators
#10 | 2012-09-13 β Patent 8,846,677 granted on 2014-09-30Medicaments
#11 | 2012-07-05 β Patent 8,329,715 granted on 2012-12-11Tricyclic compounds as modulators of TNF-Ξ± synthesis and as PDE4 inhibitors
#12 | 2012-04-26 β Patent 8,350,039 granted on 2013-01-08Substituted isoquinoline derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors
#13 | 2012-04-26SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE AS BETA-SECRETASE INHIBITORS
#14 | 2012-03-22SUBSTITUTED PYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE TO TREAT OXIDATIVE STRESS
#15 | 2012-02-23NOVEL COMPOUNDS, THEIR PREPARATION AND USE
#16 | 2012-02-02 β Patent 8,513,430 granted on 2013-08-20Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta HSD1 modulators
#17 | 2012-01-12 β Patent 8,383,668 granted on 2013-02-2611-beta-hydroxysteroid dehydrogenase type 1 active compounds
#18 | 2012-01-0511-Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds
#19 | 2011-12-22PHARMACEUTICAL USE OF SUBSTITUTED AMIDES
#20 | 2011-10-06 β Patent 8,362,016 granted on 2013-01-29Phenyl propionic acids as PPAR delta activators
#21 | 2011-09-29 β Patent 8,450,354 granted on 2013-05-28Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as Ξ²-secretase inhibitors
#22 | 2011-09-15 β Patent 8,927,549 granted on 2015-01-06Adamantyl benzamide derivatives
#23 | 2011-08-18 β Patent 8,759,535 granted on 2014-06-24Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
#24 | 2011-07-28 β Patent 8,217,086 granted on 2012-07-10Phenoxy acetic acids as PPAR delta activators
#25 | 2011-06-30 β Patent 8,853,226 granted on 2014-10-07Tricyclic compounds as modulators of TNF-Ξ± synthesis and as PDE4 inhibitors
#26 | 2011-06-30 β Patent 8,383,644 granted on 2013-02-26Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
#27 | 2011-03-24 β Patent 8,318,927 granted on 2012-11-276-(4-cyclopropylpiperazin-1-yl)-2β²-methyl-[3, 4β²]-bipyridine and its uses as a medicament
#28 | 2011-03-17 β Patent 8,598,353 granted on 2013-12-03Benzazole derivatives, compositions, and methods of use as Ξ²-secretase inhibitors
#29 | 2011-02-17 β Patent 8,383,820 granted on 2013-02-26N-adamantyl benzamides as inhibitors of 11-Ξ²-hydroxysteroid dehydrogenase
#30 | 2011-01-13Histamine H3 Receptor Ligands
#31 | 2010-12-30 β Patent 8,334,305 granted on 2012-12-18N-adamantyl benzamides as inhibitors of 11-Ξ²-hydroxysteroid dehydrogenase
#32 | 2010-11-25 β Patent 8,394,842 granted on 2013-03-12Benzothiazoles having histamine H3 receptor activity
#33 | 2010-11-18 β Patent 8,053,447 granted on 2011-11-0811Ξ²-hydroxysteroid dehydrogenase type 1 active compounds
#34 | 2010-10-21 β Patent 8,344,001 granted on 2013-01-01Heterocyclic H3 antagonists
#35 | 2010-10-19 β Patent 7,816,385 granted on 2010-10-19Dimeric dicarboxylic acid derivatives, their preparation and use
#36 | 2010-08-19Novel Compounds, Their Preparations and Use
#37 | 2010-08-05PHARMACEUTICAL USE OF FUSED 1,2,4-TRIAZOLES
#38 | 2010-08-03 β Patent 7,767,695 granted on 2010-08-03Substituted piperidines
#39 | 2010-07-29 β Patent 7,964,608 granted on 2011-06-21Tricyclic compounds as modulators of TNF-Ξ± synthesis
#40 | 2010-05-1311Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds
#41 | 2010-05-06 β Patent 7,939,690 granted on 2011-05-10Haloalkylsulfone substituted compounds useful for treating obesity and diabetes
#42 | 2010-04-08 β Patent 8,383,683 granted on 2013-02-26Pharmaceutical use of substituted amides
#43 | 2010-03-25 β Patent 8,153,798 granted on 2012-04-10Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors
#44 | 2010-03-25NOVEL SALICYLIC ANILIDES
#45 | 2010-03-11 β Patent 7,915,299 granted on 2011-03-292-(2-hydroxyphenyl)benzimidazoles useful for treating obesity and diabetes
#46 | 2010-03-04 β Patent 8,563,742 granted on 2013-10-22Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use
#47 | 2010-01-14 β Patent 8,048,908 granted on 2011-11-0111Ξ²-hydroxysteroid dehydrogenase type 1 active compounds
#48 | 2009-12-31 β Patent 7,893,267 granted on 2011-02-22Benzazole derivatives, compositions, and methods of use as Ξ²-secretase inhibitors
#49 | 2009-12-31 β Patent 8,022,066 granted on 2011-09-202-(2-hydroxyphenyl) benzothiadiazines useful for treating obesity and diabetes
#50 | 2009-12-17 β Patent 8,501,739 granted on 2013-08-06Medicaments
#51 | 2009-10-22Novel Aryl- and Heteroarylpiperazines
#52 | 2009-10-22Amide Derivatives and Pharmaceutical Use Thereof
#53 | 2009-10-22Combination Therapy Using An 11beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor And A Glucocorticoid Receptor Agonist To Minimize The Side Effects Associated With Glucocorticoid Receptor Agonist Therapy
#54 | 2009-08-20 β Patent 7,968,723 granted on 2011-06-28Compounds, their preparation and use
#55 | 2009-07-30 β Patent 7,943,669 granted on 2011-05-17Phenoxy acetic acids as PPAR delta activators
#56 | 2009-07-09 β Patent 8,378,097 granted on 2013-02-193-(1,3-benzodioxol-5-yl)-6-(4-cyclopropylpiperazin-1-yl)-pyridazine, its salts and solvates and its use as histamine H3 receptor antagonist
#57 | 2009-05-07 β Patent 8,053,431 granted on 2011-11-08Pharmaceutical use of substituted amides
#58 | 2009-04-09 β Patent 7,943,613 granted on 2011-05-17Compounds, their preparation and use
#59 | 2009-02-19 β Patent 7,943,612 granted on 2011-05-17Compounds that modulate PPAR activity, their preparation and use
#60 | 2009-01-08 β Patent 8,053,598 granted on 2011-11-08Compounds, their preparation and use
#61 | 2009-01-01 β Patent 7,645,791 granted on 2010-01-12Salicylic anilides
#62 | 2008-06-26 β Patent 7,723,323 granted on 2010-05-25Pharmaceutical use of fused 1,2,4-triazoles
#63 | 2008-05-15 β Patent 7,799,924 granted on 2010-09-21Substituted homopiperidine, piperidine or pyrrolidine derivatives
#64 | 2006-12-21 β Patent 7,709,528 granted on 2010-05-04Compounds, their preparation and use
#65 | 2006-05-25 β Patent 7,501,405 granted on 2009-03-10Combination therapy using an 11Ξ²-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders
#66 | 2006-05-18 β Patent 7,582,673 granted on 2009-09-01Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use
#67 | 2006-04-27 β Patent 7,700,583 granted on 2010-04-2011Ξ²-hydroxysteroid dehydrogenase type 1 active compounds
Also check out High Point Pharmaceuticals, LLC's (High Point, United States) applicant profile with 5 patent applications submitted.
19700 β